Transgene Biotek informs about quarterly statement of investor complaint

13 Jan 2016 Evaluate

Transgene Biotek has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2015, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Transgene Biotek Share Price

2.46 0.00 (0.00%)
20-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 6903.20
Max Healthcare Inst 987.60
Narayana Hrudayalay 1801.40
Aster DM Healthcare 551.40
Global Health 1074.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×